NPI registry status
Active
2026 NPPES data Otology & Neurotology Physician NPI 1982824884 M.D.
Verify on CMS → Mark Bassim, M.D.
Otology & Neurotology Physician in Cleveland, Ohio.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 344 in Otology & Neurotology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
391
Medicare Part D claims · 154 beneficiaries · Otology & Neurotology Physician avg: 421
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$420.73
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Bassim, M.D. filed 391 Medicare Part D claims in 2024 as an Otology & Neurotology Physician in Cleveland, Ohio, prescribing 96% generic.
- 391
- Part D claims, 2024
- 96%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Bassim, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1982824884), first enumerated 04/26/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 391 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$420.73 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Ohio statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Bassim, M.D.'s individual license status. Verify directly with the state medical board.
Source: OMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1982824884 · Otology & Neurotology Physician
NPI-10 · ENUM-MID · TAX-TRACE · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1982824884
- ENUM-MID 2007
- TAX-TRACE 344
- RX-LIGHT 391
- BOOK-THIN 11 in Ohio
- PHOTO-ENUM Gregory Basura, M.D.… · 2007
Mark Bassim, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
391 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Mark Bassim, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Bassim, M.D.?
Quality data not reportedPrimary specialty
Otology & Neurotology Physician
Medicare Part D claims
391 7% vs specialty avg
Specialty distribution in Ohio
How Otology & Neurotology Physician compares to other specialties among Ohio providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Otology & Neurotology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1982824884 |
|---|---|
| Specialty | Otology & Neurotology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/26/2007 |
Hospital and facility affiliations
Facilities where Mark Bassim, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Cleveland Clinic
★★★★☆ 4/5
Cleveland, OH
Acute Care Hospitals
CMS CCN: 360180
Vantage Physical Therapy And Rehabilitation Inc
Johnstown, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Bassim, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$421
Largest payer
Grace Medical, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Ohio OMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 - they are NOT specific to Mark Bassim, M.D.. To verify Mark Bassim, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Mark Bassim, M.D. - brand share 4.0%
Otology & Neurotology Physician average
4% brand-name claims vs 96% generic, on 391 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
391
Total Claims
$10K
Total Drug Cost
154
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 459.733
- Total Day Supply
- 10,436
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $3K
- Generic Drug Cost
- $7K
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 1.52
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 25, 65-74: 72, 75-84: 43, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Bassim, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluticasone Propio…
Fluticasone Propionate
74 claims
- Azelastine Hcl
Azelastine Hcl
72 claims
- Ofloxacin
Ofloxacin
38 claims
- Amitriptyline Hcl
Amitriptyline Hcl
31 claims
- Tobramycin-Dexamet… 20
Tobramycin-Dexamethasone
20 claims
- Verapamil Hcl 18
Verapamil Hcl
18 claims
- Prednisone 17
Prednisone
17 claims
- Mupirocin 15
Mupirocin
15 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 74 |
| Azelastine Hcl | 72 |
| Ofloxacin | 38 |
| Amitriptyline Hcl | 31 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 20 |
| Verapamil Hcl | 18 |
| Prednisone | 17 |
| Mupirocin | 15 |
| Alprazolam | 13 |
| Dexamethasone Sodium Phosphate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otology & Neurotology Physician Overview
How Mark Bassim, M.D. fits within the Otology & Neurotology Physician landscape nationally.
344
Otology & Neurotology Physician Providers in US
47
States with Otology & Neurotology Physician
421
Avg Claims per Provider
Mark Bassim, M.D.'s 391 claims are below the specialty average of 421.
Nationwide Otology & Neurotology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bassim, both outside Ohio so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otology & Neurotology Physician Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as Bassim.
One of 11 Otology & Neurotology Physician providers enrolled in Ohio, 5 are shown here.
Dr. Leonard Berenholz
M.D.
Warren, OH
Dr. Edward Doyle
M.D.
Cincinnati, OH
Dr. Robert Goldenberg
MD
Dayton, OH
Dr. Stanley Lesinski
MD
Cincinnati, OH
Dr. Nauman Manzoor
M.D.
Cleveland, OH
Compare Otology & Neurotology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Bassim, M.D.'s specialty? ▼
Mark Bassim, M.D. specializes in Otology & Neurotology Physician and practices in Cleveland, Ohio. Credentials: M.D..
How much does Mark Bassim, M.D. prescribe under Medicare Part D? ▼
In 2024, Mark Bassim, M.D. wrote 391 Medicare Part D claims totaling $10K in drug costs for 154 beneficiaries.
Where is Mark Bassim, M.D. located? ▼
Mark Bassim, M.D. is located at 9500 EUCLID AVE # A71, Cleveland, OH, 44195. Phone: (216) 444-6696.
What is Mark Bassim, M.D.'s NPI number? ▼
Mark Bassim, M.D.'s National Provider Identifier (NPI) is 1982824884, issued on 04/26/2007.
Does Mark Bassim, M.D. prescribe more brand-name or generic drugs? ▼
Mark Bassim, M.D.'s prescribing is 4% brand-name and 96% generic drugs by claim count, with $3K in brand drug costs.
How many Otology & Neurotology Physician providers are there in the US? ▼
There are 344 Otology & Neurotology Physician providers across 47 states in the US. The average Otology & Neurotology Physician provider writes 421 Medicare Part D claims per year.
What drugs does Mark Bassim, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Bassim, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Azelastine Hcl, Ofloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Bassim, M.D. accept Medicare? ▼
Mark Bassim, M.D. appears in CMS Medicare data with 391 Part D claims and 154 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Bassim, M.D.'s credentials? ▼
Mark Bassim, M.D.'s NPI is 1982824884 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.